Atea Pharmaceuticals, Inc. - common stock (AVIR) SEC filings
AVIR SEC filings moved a median of -1.84% by the close. AVIR SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the AVIR overview →
45 measured AVIR SEC filing events.
Where these AVIR SEC filings landedvs 43 measured AVIR SEC filing reactions
| Middle 50% of AVIR SEC filing reactions | -4.21% to +2.34% |
|---|---|
| Median reaction (to close) | -1.84% |
| Measured reactions | 43 |
Point-in-time · zero look-ahead
Half of the 43 AVIR SEC filing events with a measured close landed between -4.21% and +2.34%; 47% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Atea Pharmaceuticals, For: Jun 30 | SEC filing · Form 10-Q | +3.65% | -2.69% | |
| Form 8-K Atea Pharmaceuticals, For: Aug 12 | SEC filing · Form 8-K | +3.65% | -2.69% | |
| Form 8-K Atea Pharmaceuticals, For: Jun 18 | SEC filing · Form 8-K | +2.29% | +2.52% | |
| Form 10-Q Atea Pharmaceuticals, For: Mar 31 | SEC filing · Form 10-Q | -4.38% | -12.95% | |
| Form 8-K Atea Pharmaceuticals, For: May 12 | SEC filing · Form 8-K | -4.38% | -12.95% | |
| Form DEF 14A Atea Pharmaceuticals, For: Jun 18 | SEC filing · Form DEF | -0.37% | +4.10% | |
| Form DEFA14A Atea Pharmaceuticals, | SEC filing · Form DEFA14A | -0.37% | +4.10% | |
| Form 10-K Atea Pharmaceuticals, For: Dec 31 | SEC filing · Form 10-K | +6.64% | +22.20% | |
| Form 8-K Atea Pharmaceuticals, For: Mar 05 | SEC filing · Form 8-K | +6.64% | +22.20% | |
| Form 8-K Atea Pharmaceuticals, For: Jan 08 | SEC filing · Form 8-K | +1.45% | +4.94% | |
| Form 10-Q Atea Pharmaceuticals, For: Sep 30 | SEC filing · Form 10-Q | +2.50% | — | |
| Form 8-K Atea Pharmaceuticals, For: Nov 12 | SEC filing · Form 8-K | +2.50% | — | |
| Form 10-Q Atea Pharmaceuticals, For: Jun 30 | SEC filing · Form 10-Q | -0.56% | -6.11% | |
| Form 8-K Atea Pharmaceuticals, For: Aug 07 | SEC filing · Form 8-K | -0.56% | -6.11% | |
| Form S-8 Atea Pharmaceuticals, | SEC filing · Form S-8 | -0.56% | -6.11% | |
| Form 8-K Atea Pharmaceuticals, For: Jun 20 | SEC filing · Form 8-K | -0.61% | +2.15% | |
| Form 10-Q Atea Pharmaceuticals, For: Mar 31 | SEC filing · Form 10-Q | +0.86% | -9.31% | |
| Form 8-K Atea Pharmaceuticals, For: May 12 | SEC filing · Form 8-K | +0.86% | -9.31% | |
| Form DEF 14A Atea Pharmaceuticals, For: Jun 20 | SEC filing · Form DEF | +0.34% | +1.38% | |
| Form 8-K Atea Pharmaceuticals, For: Apr 16 | SEC filing · Form 8-K | +0.65% | -4.19% | |
| Form DEFA14A Atea Pharmaceuticals, | SEC filing · Form DEFA14A | +6.07% | -0.36% | |
| Form 8-K Atea Pharmaceuticals, For: Mar 31 | SEC filing · Form 8-K | +0.51% | -3.72% | |
| Form DEFA14A Atea Pharmaceuticals, | SEC filing · Form DEFA14A | +0.51% | -3.72% | |
| Form DEFA14A Atea Pharmaceuticals, | SEC filing · Form DEFA14A | +0.00% | -3.82% | |
| Form 8-K Atea Pharmaceuticals, For: Mar 21 | SEC filing · Form 8-K | +0.92% | -1.84% | |
| Form DEFA14A Atea Pharmaceuticals, | SEC filing · Form DEFA14A | +0.92% | -1.84% | |
| Form 10-K Atea Pharmaceuticals, For: Dec 31 | SEC filing · Form 10-K | +3.57% | +3.46% | |
| Form 8-K Atea Pharmaceuticals, For: Mar 06 | SEC filing · Form 8-K | +3.57% | +3.46% | |
| Form 8-K Atea Pharmaceuticals, For: Feb 20 | SEC filing · Form 8-K | -0.32% | +0.96% | |
| Form 8-K Atea Pharmaceuticals, For: Jan 13 | SEC filing · Form 8-K | +1.25% | -1.87% | |
| Form EFFECT Atea Pharmaceuticals, | SEC filing · Form EFFECT | +0.00% | +1.28% | |
| Form 8-K Atea Pharmaceuticals, For: Nov 07 | SEC filing · Form 8-K | -1.72% | +0.29% | |
| Form S-3 Atea Pharmaceuticals, | SEC filing · Form S-3 | -1.72% | +0.29% | |
| Form 10-Q Atea Pharmaceuticals, For: Jun 30 | SEC filing · Form 10-Q | -0.61% | +6.71% | |
| Form 8-K Atea Pharmaceuticals, For: Aug 07 | SEC filing · Form 8-K | -0.61% | +6.71% | |
| Form 8-K Atea Pharmaceuticals, For: Jun 21 | SEC filing · Form 8-K | +1.45% | +1.45% | |
| Form DEFA14A Atea Pharmaceuticals, | SEC filing · Form DEFA14A | +1.32% | +4.21% | |
| Form 10-Q Atea Pharmaceuticals, For: Mar 31 | SEC filing · Form 10-Q | +2.10% | -2.63% | |
| Form 8-K Atea Pharmaceuticals, For: May 14 | SEC filing · Form 8-K | +2.10% | -2.63% | |
| Form DEF 14A Atea Pharmaceuticals, For: Jun 21 | SEC filing · Form DEF | +0.27% | +0.27% | |
| Form DEFA14A Atea Pharmaceuticals, | SEC filing · Form DEFA14A | +0.27% | +0.27% | |
| Form 10-K Atea Pharmaceuticals, For: Dec 31 | SEC filing · Form 10-K | -0.89% | -4.22% | |
| Form 8-K Atea Pharmaceuticals, For: Feb 28 | SEC filing · Form 8-K | -0.89% | -4.22% | |
| Form 10-Q Atea Pharmaceuticals, For: Sep 30 | SEC filing · Form 10-Q | +1.11% | -5.38% | |
| Form 8-K Atea Pharmaceuticals, For: Nov 08 | SEC filing · Form 8-K | +1.11% | -5.38% |
Keep exploring
More AVIR: earnings → · analyst actions → · AVIR overview →